MedHub Ltd., a medical technology company specializing in AI-powered non-invasive arterial physiological assessment technologies, has announced the appointment of Dr. Justin Davies as the company’s president. Dr. Davies is a leading medical device entrepreneur and a pioneer of the instantaneous wave-free ratio (iFR) technique.
As MedHub continues to implement its go-to-market strategy, the inclusion of Dr. Justin Davies to the team will provide further expertise and capabilities to the company. Justin has a proven track record of helping small and medium-sized companies gain a leading market position.
“We are thrilled to have a leading industry expert with Dr. Justin Davies’ extensive medical device development expertise join our company,” said Or Bruch-El, CEO of MedHub. “Justin is a distinguished cardiologist and medical-device entrepreneur known worldwide for his ceaseless innovations and stewardship of successful med-tech companies. His insights will be instrumental as we roll-out our marketing program and invest in collaboration opportunities.”
Dr. Davies completed his undergraduate training and PhD at Imperial after being awarded a British Heart Foundation research fellowship. Dr. Davies is a leading clinical academic in the field of interventional cardiology and has pioneered several new techniques, including coronary wave intensity and instantaneous wave-free ratio (iFR). He has also published extensively in the field of hypertension and coronary and large artery physiology.
Additionally, MedHub is pleased to disclose the progression in the development of the AutocathTL (Tandem Lesion) system, with more information to be revealed soon. This initiative represents the natural evolution from the well-established AutocathFFR technology, underscoring MedHub’s unwavering commitment to innovation in the coronary physiology space.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
